Hanmi Pharm (128940) stock
Hanmi Pharm technical analysis
Oscillators
Summary
Moving averages
| Oscillators | Value | Signal |
|---|---|---|
| RSI (14) | 61.24 | Neutral |
| Stochastic %K (14, 3, 3) | 69.31 | Neutral |
| CCI (20) | 93.44 | Neutral |
| ADX (14) | 35.12 | Buy |
| Awesome Oscillator | 24,243.38 | Neutral |
| Momentum (10) | 8,000 | Buy |
| MACD (12, 26) | 15,211.78 | Sell |
| Stoch RSI (3, 3, 14, 14) | 53.74 | Neutral |
| Williams %R (14) | -13.41 | Neutral |
| Bull Bear Power | 19,368.63 | Buy |
| Ultimate Oscillator (7, 14, 28) | 51.11 | Neutral |
| Moving averages | Value | Signal |
|---|---|---|
| EMA (10) | ₩505,496.30 | Buy |
| SMA (10) | ₩506,650.00 | Buy |
| EMA (20) | ₩495,399.44 | Buy |
| SMA (20) | ₩495,700.00 | Buy |
| EMA (30) | ₩484,155.09 | Buy |
| SMA (30) | ₩494,416.67 | Buy |
| EMA (50) | ₩468,083.08 | Buy |
| SMA (50) | ₩448,510.00 | Buy |
| EMA (100) | ₩455,765.63 | Buy |
| SMA (100) | ₩437,800.00 | Buy |
| EMA (200) | ₩442,600.76 | Buy |
| SMA (200) | ₩467,915.00 | Buy |
| Ichimoku Base Line (9, 26, 52, 26) | ₩492,500.00 | Buy |
| VWMA (20) | ₩495,347.27 | Buy |
| Hull MA (9) | ₩506,011.11 | Buy |
Support & resistance levels
Resistance
- R3₩645,013.45+23.33%Moderate
- R2₩570,739.41+9.13%Moderate
- R1₩539,398.89+3.14%Moderate
Support
- S1₩438,536.14-16.15%Strong
Levels are detected automatically from swing highs and lows on the daily chart and clustered by volatility (ATR). Strength reflects the number of times price reacted at each level.
| Pivot points (daily) | S3 | S2 | S1 | P | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | ₩482,166.67 | ₩487,333.33 | ₩496,666.67 | ₩501,833.33 | ₩511,166.67 | ₩516,333.33 | ₩525,666.67 |
| Fibonacci | ₩487,333.33 | ₩492,872.33 | ₩496,294.33 | ₩501,833.33 | ₩507,372.33 | ₩510,794.33 | ₩516,333.33 |
| Camarilla | ₩502,012.50 | ₩503,341.67 | ₩504,670.83 | ₩501,833.33 | ₩507,329.17 | ₩508,658.33 | ₩509,987.50 |
| Woodie | ₩484,250.00 | ₩488,375.00 | ₩498,750.00 | ₩502,875.00 | ₩513,250.00 | ₩517,375.00 | ₩527,750.00 |
| DeMark | — | — | ₩499,250.00 | ₩503,125.00 | ₩513,750.00 | — | — |
Hanmi Pharm price forecast
| Horizon | Bear case (95%) | Low (68%) | Trend target | High (68%) | Bull case (95%) |
|---|---|---|---|---|---|
| 5 trading days | ₩413,911.40 | ₩469,312.18 | ₩532,128.18 +1.7% | ₩603,351.91 | ₩684,108.72 |
| 21 trading days | ₩336,090.50 | ₩434,769.99 | ₩562,422.75 +7.5% | ₩727,555.62 | ₩941,173.13 |
| 63 trading days | ₩266,616.60 | ₩416,424.45 | ₩650,407.07 +24.4% | ₩1,015,861.00 | ₩1,586,657.99 |
The technical bias for Hanmi Pharm is bullish (overall rating: Strong Buy).
Bullish scenario: a sustained break above ₩539,398.89 would open the way toward ₩570,739.41.
Bearish scenario: a daily close below ₩438,536.14 could extend the decline toward ₩416,609.33.
Statistical ranges are based on historical volatility and trend, not a guarantee of future prices. Not financial advice.
About Hanmi Pharm
Hanmi Pharm (128940) shares are trading at ₩523,000.00, up +3.36% today. The company belongs to the Health Care sector and has a market capitalization of ₩6.64T.
The stock’s 52-week range is ₩297,000.00 – ₩647,000.00, with a price-to-earnings ratio of —. It has moved +0.20% over the past week and +30.24% over the past month.
On the daily chart the overall technical rating for Hanmi Pharm is Strong Buy, with the 14-day RSI at 61.2. The nearest support is at ₩438,536.14 and the nearest resistance at ₩539,398.89.
Related markets
AllStock market news
-
My wife never went back to work after raising our kids. Do I have to share my retirement savings 50/50?MarketWatch.com29 min. ago
-
Marvell just impressed Wall Street with ‘good numbers plus a better story’MarketWatch.com34 min. ago
-
What’s Next for Nvidia, Apple, and Other Trillion-Dollar Stocks?Barron's37 min. ago
-
How Meta’s stock can surge to $1,000, according to the biggest bull on Wall StreetMarketWatch.com39 min. ago
-
Growth stocks outperform value in broad market advanceFox Business49 min. ago
-
Stocks hit new record high even as consumers feel drearyThe Washington Post55 min. ago
-
Consumer Internet Stocks Q2 In Review: Booking (NASDAQ:BKNG) Vs PeersYahoo Finance58 min. ago